You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Speedy Sparse Bundle Adjustment for Video/Image Sequences

    SBC: VISION SYSTEMS INC            Topic: AF131151

    ABSTRACT: VSI proposes a flexible sensor estimation framework for airborne calibration processing of image streams over long time periods. The components of the framework will consist of existing software and libraries. The plugin-based framework provides flexibility to switch the components easily. The core of the framework is a belief propagation engine to globally optimize the sensor parameter ...

    SBIR Phase I 2013 Department of DefenseAir Force
  2. Biomarker discovery for immunodiagnosis of invasive candidiasis

    SBC: DXDISCOVERY INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost associated with IC in the U.S. may be as high as 2-4 billion/year. One of the most critical factors influencing patient outcome is early diagnosis. The goal of this project is a rapi and inexpensive i ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. An Automated Platform for High-throughput Network Electrophysiology

    SBC: CALISTA THERAPEUTICS INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cystic fibrosis (CF). CF is a deadly inherited genetic disorder that disrupts chloride channel function, resulting in the buildup of sticky mucus in patient's lungs and other organs.CF patients hav ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Developing an Improved Electrocompetent E. coli Host

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NCATS

    DESCRIPTION (provided by applicant): Chronic musculoskeletal pain creates a significant public health burden. Veterans are disproportionately affected by chronic musculoskeletal pain, and in particular, chronic low back pain (CLBP). The frequency and extent of co-occurrence of pain and PTSD, pain and Traumatic Brain Injury (TBI), and all three conditions (Post-deployment Multi-symptom Disorder (PM ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Selective Solar Conversion of Carbon Dioxide to Dimethyl Ether (DME) Using Unique-Architectured Nanotubular Semiconductors

    SBC: EMD Technologies, LLC            Topic: AF103252

    ABSTRACT: Carbon dioxide feed stock can be converted into fuels of solid, liquid or gas phase by chemical, electrolytic, photocatalytic and photo-electrocatalytic methods. Reduction of CO2 to fuel form of any phase requires energy. The reduction process should be energy efficient so that we do not spend more energy and emit more (indirect) CO2 in the process of converting CO2. From this point of ...

    SBIR Phase I 2012 Department of DefenseAir Force
  6. Passive Airborne Radar Using Opportunistic Signals (PASSAROS)

    SBC: Applied Radar, Inc.            Topic: AF121138

    ABSTRACT: A key requirement for a practical/scalable airborne passive radar system using opportunistic ground emitters such as broadcast TV is the ability to effectively isolate the high-powered direct-path signals from much weaker target reflected ones. Previous passive radars rely on array antennas complemented by multistatic techniques and dedicate/agile decoders for every-possible-type of opp ...

    SBIR Phase I 2012 Department of DefenseAir Force
  7. Uncertainty-based 3-d Fusion of Multi-Sensor Aerial Imagery

    SBC: VISION SYSTEMS INC            Topic: AF121165

    ABSTRACT: Multi-sensor fusion is a key capability required for effective inferences for timely and accurate strategy and tactical planning. A multi-sensor fusion technology needs to appropriately weigh different image streams according to the uncertainties and errors across different inputs and parameters such as GPS and INS measurements, sensor model parameters, inherent ambiguities of the data ...

    SBIR Phase I 2012 Department of DefenseAir Force
  8. Novel Tetravalent Vaccines for Dengue Virus

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Dengue virus infection is an emerging disease and an expanding global health problem. More than one-third of the world's population is at risk for transmission in tropical and subtropical areas and vaccines are an urgent public health priority. Although dengue rarely occurs in the continental United States, it is endemic in Puerto Rico, and in many popular ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Vaccines are urgently needed to slow the spread of the HIV/AIDS epidemic, and immunogens that can induce neutralizing antibodies remain an important goal of vaccine research. An increasing number of human monoclonal antibodies (mAbs) have been isolated in recent years from individuals who show remarkably broad and potent neutralizing responses. Coupled with pas ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Therapeutic Vaccines for Chronic HBV

    SBC: ALTRAVAX, INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Hepatitis B virus (HBV) is a noncytopathic, hepatotropic DNA virus that results in a self-limited acute infection in a majority of otherwise healthy individuals but can also cause chronic infection, particularly in newborns infected by vertical transmission. Chronic hepatitis B infection is a significant global health issue directly affecting 350 million people ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government